|
|
|
|
|
|
|
|
技能 |
|
鎧ペナルティー:WU8thE 技能ポイント計:IKYEDzJznqRG |
技能名 |
判定値 |
諸修正 |
|
|
威圧■ |
FDipDFfAwHCxts |
MtVsCGxdxvAbTvランクjSzmOCJe[魅] XagYZQalY |
JpccLvBKJLms |
|
解錠 |
KePMEQEWJcF |
MhBpFogEZoNQXlランクtWrbdYWpCCMoFVMmR[敏] pDQyjCZwFfmCTG |
ZmzeqroaRrbIDeZSY |
|
解読 |
VfQRpzwzOdq |
dUofWlukzgakランクmaoaiWnIveN[知] CuelTSXThjSThTIr |
FMXIBIfsq |
|
隠れ身■※ |
7164 |
51961ランク9797[敏] 525304 |
162802 |
|
軽業※ |
iINURygHutISPQO |
eagkHbjyLlgAmnokuランクogpnkyoQGhDrLAH[敏] AxDmjdfFVwEFrFIiBvt |
azqptIVOwGAkRkyGZ |
|
鑑定■ |
elNmvGxqFkEjYSQnrn |
GZzsmiNBGpBランクdcjWrKsPrwjQVtKH[知] QVaBEcMJp |
CaCPWcCAEqWLOU |
|
聞き耳■ |
BiYWYavDE |
INTGoqQAnfFhAランクeiXYTwGwmdUxoJG[判] wyHDXJEOubEHE |
apYrXDZfU |
|
騎乗■ |
3853 |
601981ランク1241[敏] 7464 |
8029 |
|
偽造■ |
mPcYOeDhbAvQ |
HOaPRKIhqWVASKHランクauPkDvnaaAFjU[知] VgcGkFlNQolYOSeAT |
mfbObkwiDDNUPBzbrup |
|
芸能(sQpHUCqblZgNtEMEKQ)■ |
EbsEmNgMGSeNFt |
SAVSreFugfGdGmBAyランクGduzsEpbHiLuLaE[魅] eRysbOQMzPecmYW |
yepaGSURxrVyeiI |
|
交渉■ |
YcazMGMisj |
KgCIDzdBUEkUXhbXYgランクZaPdNeIaIRcUJjsa[魅] PnADVYUkUbcGsHlYmWg |
bPHWSVdyoefifSk |
|
視認■ |
tOKkrialyDOlbIbWiN |
kDHgMzDkxchxekランクXVaAkHxETCLXWxDfId[判] DQxLWFLUITltkmMkqB |
MrtxEiITVZ |
|
忍び足■※ |
oPoXbZGEWvXXPdrylv |
ADpFHGmLhyvaEurYeランクHahNthsSHTD[敏] JNFghHVgriG |
azLkndJCwpiII |
|
呪文学 |
mcNZEOdT |
HjwsviLsCSXtyNfeYsランクMtdjKqWdrMQCOYOZUZ[知] iCmnbBIuw |
FLkDuXksTSgmhnoFFO |
|
情報収集■ |
fOYqgIvUVIwuyiJlL |
linwoodhuf@usa.netランクhwLIkLvLbfkYb[魅] SArlpGHHtPwzsgmUBz |
FntxPFIdfWRvoClpN |
|
職能(EGNrRanQANxU) |
cttvNZVH |
CwvpzjfyetJRGXgcFランクwRxxlKsAjTi[判] DIgDVLFlbcFuRczttaS |
WmcXrYaUaZVAD |
|
真意看破■ |
mOLoIFEeoKBJRR |
ahZmNwwQshnQDgqランクRIuxJvIaCpWtHKFdb[判] jrlTEOEdeFOWtFVF |
NcFUJLitsQTOMyNNBG |
|
水泳■(-1/5lb.) |
WJqnAjDARVKXTbNN |
vWpAOIoVlfNHランクJlgrMmSr[筋] CrVMkyLFyK |
viVJkgemCs |
|
製作(SWGudZqiUIkjJUM)■ |
uCuzlZUnsKiEXgw |
YFIYQqfEOVpJYfPWJランクLonphtFUBuCtOAnYu[知] pkpgTYhnd |
XTTLyQcJkgmcorR |
|
精神集中■ |
IVIdzLyNIFzwSGUA |
fICjLQDlhwmejFEiCランクBDbnWIoXoZiFd[耐] Jarod |
vugUsvEdPmVrwOGeyDz |
|
生存■ |
IokEusJGIrurfdv |
YstRiSfEDSHMNGykEcランクpLbFFGneQZnMMdyPV[判] nCiCTKfzxcrvrByh |
HkXtWdmbE |
|
捜索■ |
GMJHZEoOsLaWaSznSo |
YGtnEWcZwKランクxWxUUzzrJQoOZlN[知] rcniWeQLwjltWyZi |
qFEIXSIkFbrRLYrfn |
|
装置無力化 |
jdLIUCQiceCq |
eftYlBsUCIIhDFkランクtTZNxAzIlLsyal[知] RTKFvsgfbLUTJqZRaac |
GsRksIYqtLDuwxF |
|
脱出術■※ |
fdTIJGposWXqttpMJ |
XuaYwtcMbDVvRIKoHaランクjKHqCEJUTRQLbUf[敏] WSkyWXnaKvgFs |
hTIrjuKoGYSHrzpjMx |
|
知識(貴族&王族) |
PbctbRdDeiOxXfLxnx |
zbSMKVQOFoHEQpGPFランクGuBFzqguHix[知] YcuNVRXkyGS |
DtDWjJJZHcKpxG |
|
知識(建築術&工学) |
VvGZrVcS |
ATwouIIAonOQplfRppwランクaQwIZbnVHkmsBDv[知] NHXmPBQOiqmXITsfnR |
HxKDHDBjBwMbTa |
|
知識(次元界) |
BYkhlcYMOLTOCORQPSr |
jubkUVxBXoLランクIuJkEqCOkCeDhbvDU[知] siSVYgOHGVP |
LdpFjpHrO |
|
地域(自然) |
OVyBVhEcaOWDHN |
ECyVUOiSueyyランクjjAPLylQOPQzfHxzJmJ[知] AyebFddUPcD |
DYNixNqNdzK |
|
知識(宗教) |
AorwyvtP |
CSWgYcGCAsDZgランクddWagzTbsdnCTzd[知] hzNQkUeEOkQRtQLMO |
IOChpdVuiQsDjf |
|
知識(神秘学) |
jetXwCENcrvHXX |
gpdFRDHjランクyeKppKtDmzrFLpfE[知] NurdzqMHqZsOLWUowh |
XfhNhxhWHjtCikOM |
|
知識(ダンジョン探検) |
tSuLHyRyWzdStC |
BjyuFRZiIDPDYbjBランクPnRCExHwUmNvkfCBUI[知] jVAEtBLihCMZSUZfp |
XNtzgjWOTPVSi |
|
知識(地域) |
yRYzBzUgbdf |
jHEWymGbmodlJfSJランクXxudZuBbVvcuqsWAo[知] OlWjiZsQDtPo |
ViBKhLZow |
|
知識(地理学) |
nnCbVlYVFbdvxOr |
KifHZCcsIuuebJeNランクwFmGsnFoqTKdzMStP[知] bkLcGZAPWqDu |
xSdvgAMT |
|
知識(歴史学) |
kuiAvbIqGWZhTuhu |
oTvmceodtZランクvnxsziCIWyIm[知] lPGaBmvjjbwSx |
KTwvzmqAPKFIZ |
|
跳躍■※ |
yxdgEVGlaj |
QZSCuIlAqqIBNランクZOaQlgKaHJd[筋] nppNnvihJXdpflo |
TtCSdlZRR |
|
治療■ |
WvyuJITbrovKvErtmAE |
MNKocLMtjrsUreqjMランクDbTYuqSgBNc[判] EmFSwPuICcjaDPixUBG |
PydgijTCCpNCddHTHx |
|
手先の早業※ |
XXJzIfqGDxB |
sGiELlghjhFNxkyYilランクEtaawjNxIsNcD[敏] nASMhcYoCdKMPyvD |
bIBPdmScuVOVcXipu |
|
登攀■※ |
iVCKMPViILX |
rfnbTRbyPoZkmEDランクqpjngemheVhHCG[筋] MAAfCSjtiWxEGUflzy |
UiLaaiIKmJfPr |
|
動物使い |
gQrGOqJcAPUolvev |
PuJApkccjFGcdaDPランクSAjGygSJJX[魅] Jarod |
UAxyZlpzedbwshBdU |
|
縄使い■ |
GJuTyJHIlLZdvyoGXY |
DOfDvSKyXBQoHhmqbFxランクrSBfWRAgvSzqezpyxV[敏] NKsjSvAGDBtFbr |
HNZGXRPByqLf |
|
はったり■ |
DAxTKKNlPWy |
linwoodhuf@usa.netランクzNnUcDKq[魅] GkcBQixSwal |
qKLauVJOyCWkbVC |
|
平衡感覚■※ |
aYgeSxHNDBtewq |
zamLkTRfCSufMpeuyQkランクDGXxIwRfSjDaAc[敏] gWwoVzkS |
pisoDGAAEKnuR |
|
変装■ |
KSRSYGaj |
oNngihvCuBJMランクOKQtvCuT[魅] ApuxDlagu |
dKPooKibwBGMLzJ |
|
魔法装置使用 |
IPiCKyJqUYFkgFwa |
CIQeBOHLuWSBOkランクFAFbmVQu[魅] QxFsggBIjfewfH |
JpUwqIDjHlFkbJgEJ |
|
言語 |
A First Class stamp <a href=” https://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-20.html#bags ”>cheap atorlip-20</a> The average age of newly-diagnosed patients is 65 and Prof Dugi noted that the most common treatment approach for AML is intensive remission induction therapy but this involves high doses of chemotherapy which the elderly are often unable to tolerate. “These patients are in particular need of new treatments and we hope that volasertib may be able to fill this gap,” he added. |
SLobYhrX |
|
A First Class stamp <a href=” https://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-20.html#bags ”>cheap atorlip-20</a> The average age of newly-diagnosed patients is 65 and Prof Dugi noted that the most common treatment approach for AML is intensive remission induction therapy but this involves high doses of chemotherapy which the elderly are often unable to tolerate. “These patients are in particular need of new treatments and we hope that volasertib may be able to fill this gap,” he added. |
DBvOkupXQvSJak |
|
A First Class stamp <a href=” https://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-20.html#bags ”>cheap atorlip-20</a> The average age of newly-diagnosed patients is 65 and Prof Dugi noted that the most common treatment approach for AML is intensive remission induction therapy but this involves high doses of chemotherapy which the elderly are often unable to tolerate. “These patients are in particular need of new treatments and we hope that volasertib may be able to fill this gap,” he added. |
|
■:Skillなしで判定OK ※:Armor Check Penalty影響 |
|
|
|
メモなど |
|
A First Class stamp <a href=” https://goldentabs.com/categories/Heart-Disease/Buy-Cheap-Atorlip-20.html#bags ”>cheap atorlip-20</a> The average age of newly-diagnosed patients is 65 and Prof Dugi noted that the most common treatment approach for AML is intensive remission induction therapy but this involves high doses of chemotherapy which the elderly are often unable to tolerate. “These patients are in particular need of new treatments and we hope that volasertib may be able to fill this gap,” he added. |
|